These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 11086366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M, Hee A, Emeribe U, Silberstein S.
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cost effectiveness of stratified care in the management of migraine.
    Williams P, Dowson AJ, Rapoport AM, Sawyer J.
    Pharmacoeconomics; 2001; 19(8):819-29. PubMed ID: 11596834
    [Abstract] [Full Text] [Related]

  • 10. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S.
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [Abstract] [Full Text] [Related]

  • 11. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
    Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.
    Curr Med Res Opin; 1999 Mar; 15(4):282-9. PubMed ID: 10640260
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    Bussone G, D'Amico D, McCarroll KA, Gerth W, Lines CR.
    Eur Neurol; 2002 Jan; 48(3):172-7. PubMed ID: 12373035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zolmitriptan: a review of its use in migraine.
    Spencer CM, Gunasekara NS, Hills C.
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.